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Effects of Concurrent Administration of
Lead, Cadmium, and Arsenic in the Rat
by Kathryn R. Mahaffey* and Bruce A. Fowlert
Humans are exposed to a number of toxic elements in the environment; however, most experiments
with laboratory animals investigate only one toxic element. To determine ifconcomitant exposure to lead
(Pb), cadmium (Cd), and/or arsenic (As) modified the changes produced by any one metal in various
parameters oftoxicity, 168 male, Sprague-Dawley, young adult rats were fed nutritionally adequate diets
to which had been added 0 or 200 ppm Pb as Pb acetate, or 50 ppm Cd as Cd chloride, or 50 ppm As as
sodium arsenate or arsanilic acid in a factorial design for a period of 10 weeks.
At these concentrations, Cd and As reduced weight gain even when differences in food intake were
taken into account; administration of both Cd and As depressed weight gain more than did either metal
alone. Pb did not adversely affect food consumption or weight gain. Increased numbers ofred blood cells
(RBCs) were observed following administration ofPb, Cd, or As; usually more cells were observed when
two or three metals were administered, compared to individual metals. Despite increasing numbers of
circulating RBCs, hemoglobin and hematocrit were reduced, especially with the Pb-Cd combination and
the Cd-arsanilic acid combination. Specific effects of Pb on heme synthesis were observed, including
increased urinary excretion of8-aminolevulinic acid; this increase was reduced by the presence ofdietary
cadmium.
Analyses of blood showed values for the laboratory rat within normal ranges for blood urea nitrogen,
creatinine, cholesterol, calcium, albumin, total protein, and bilirubin. Uric acid was increased by Pb,
with little modification by dietary Cd or As content. Serum glutamate-oxalate transaminase activity was
reduced by As. Serum alkaline phosphatase was greatly reduced by either As or Cd but not Pb. Combina-
tions of As and Cd did not further reduce the activity of this enzyme. Kidney weight and kidney
weight/body weightratios were increased by Pb alone, with no effects ofCd or As alone or as interactions.
Liver weight/body weight ratios were reduced in animals fed 50 ppm dietary Cd. Kidney histology shows
predominantiy Pb effects, namely, intranuclear inclusion bodies and cloudy swelling. Ultrastructural
evaluation ofkidneys from Pb-treated animals disclosed nuclear inclusion bodies ofthe usual morphology
and mitochondrial swelling. Concurrent administration of Cd greatiy minimized Pb effects on the kidney
under conditions ofthis experiment. Liver histology suggests an increased rate ofcell turnover with either
As compound, but few specific changes.
Introduction
Human populations are seldom exposed to only
one toxic element in the environment. While a great
deal of research utilizing experimental animals has
been carried out to study the effects of metals, the
great majority ofthis work has involved administra-
tion of one toxic metal. The current experiment was
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undertaken to determine if concurrent administra-
tion of lead, cadmium, and arsenic, changed the
severity or type ofeffect produced by the individual
metals, i.e., if interactive effects occurred.
Changes in the renal, hematopoietic, and hepatic
systems were ofspecial interest because Pb (1), Cd
(2), and As (3) each have effects on these systems.
For example, Pb, Cd, and As each affect specific
steps in heme and porphyrin synthesis or
metabolism which may not be rate-limiting under
conditions of exposure to individual metals. How-
ever, their combined effect might produce anemia
as shown by decreased hemoglobin concentration
or hematocrit.
August 1977 165Materials and Methods
One hundred and sixty-eight, male, albino,
Sprague-Dawley, young, adult rats were fed nutri-
tionally adequate, casein-based purified diets (4) for
a period of 10 weeks. There were 14 animals per
group. The diets contained background or high
levels ofCd, Pb, or As and were arranged in a 2 x 2
x 2 factorial design (Table 1). The background
levels were less than 20 ppb for Cd and As and less
than 50 ppb for Pb. Lead was added at the level of
200 ppm in the form of Pb acetate. Cd was added
as CdCl2 at 50 ppm Cd and As as sodium arsenate
Table 1. Experimental design, showing number
of animals per group.a
<0.05 ppm As 50 ppm As
<0.05 ppm Pb 200ppm Pb <0.05 ppm Pb 200ppm Pb
<0.02
ppm Cd 14 14 14 14
50ppm
Cd 14 14 14 14
aAs as arsenilic acid or sodium arsenate; Pb as lead acetate;
Cd as cadmium chloride.
(Inorg As) in one set of diets and as arsanilic acid
(Org As) in another set of diets. Analyses of the
diets showed that the actual metal content was
within 10% ofthese calculated values. The purpose
oftesting these two forms ofAs was to determine if
differences in tissue concentrations or toxicity due
to chemical form of As would occur at the end of
the 10-week period. Tissue concentrations of the
metals are not yet available and will be reported
later. Concentrations ofthese metals in brain, bone,
liver, and kidney will be measured by plasma emis-
sion spectroscopy which will determine concentra-
tions ofapproximately 20 trace elements. This type
ofanalysis will provide considerable information on
interactions between various essential and toxic
metals and may provide insight on the mechanisms
of toxicity. Some of the parameters measured in
this study were initial body weight, final body
weight, food consumption, blood pressure (sys-
tolic), hemoglobin, hematocrit, and red blood
count, porphyrin intermediates, clinical chemistries
(blood), kidney and liver weights, light and electron
microscopy ofliver and kidney, blood lead concen-
tration, blood, brain, kidney, and liver concentra-
tions of As, Cd, and Pb. Generally, they are stan-
dard clinical measurements used in assessment of
toxicity. Hemoglobin was measured by a
cyanohemoglobin technique (5), and blood urea ni-
trogen, creatinine, cholesterol, calcium, albumin,
total protein, bilirubin, uric acid, alkaline phos-
phatase and glutamate-oxalate transaminase
(SGOT) by the respective methods cited (6-15).
Urinary 8-aminolevulinic acid (dALA) was
measured by the technique reported by Davis and
Andelman (16).
Fixation and processing ofliver and kidney tissue
for histological and ultrastructural examination
were conducted by previously described methods
and instrumentation (17).
Choice of the rat as the experimental animal in
this study was based on its usefulness for investiga-
tions of the effects of Pb, Cd, and As. The rat will
readily consume a purified diet in which the con-
centrations of the metal can be closely controlled
and the nutritional requirements of the rat are well
known. These were considered to be important fac-
tors in an experiment of this type in which metal
interactions are of interest. Although the rat may
have an unusual distribution of tissue arsenic (3)
this difference was considered of smaller impor-
tance in a longer term toxicity study than in short
term metabolic experiments.
Concentrations of Pb (4), Cd (17), and As (18, 19)
to be incorporated into the diet were based on in-
formation from previous investigations. Concentra-
tions were selected which would produce slight to
moderate toxicity, that is, tissue accumulation of
the metal with demonstrable morphologic and
biochemical changes. The data reported are the re-
sults of statistical evaluation using the analysis of
variance technique. Levels of significance are
shown in each table. In the tables the p value for a
main effect or an interaction is reported beside the
treatment. This does not mean that the number be-
side the significance level differs from control but
that the overall effect is significant at the magnitude
specified in the footnote.
Results
The quantity of food ingested was not signifi-
cantly affected by the level of Pb or Cd in the diet
(Table 2), but was reduced by addition of50 ppm of
either form of As to the diet. Weight gain was re-
duced more by both As and Cd than by Pb. Be-
cause the weight reduction observed in animals fed
the As diets could be due to reduced food intake,
utilization offeed or efficiency ofutilization offeed
was calculated. Food efficiency utilization was re-
duced when either Cd or As were fed at the concen-
trations used in these diets (Table 2). The combined
effects ofCd and As were to reduce the food utiliza-
tion even more than that which occurred with either
metal alone.
Administration of Pb, Cd, or As resulted in an
increase in the number ofcirculating red blood cells
(Table 3). Combinations ofmetals usually produced
Environmental Health Perspectives 166Table 2. Food consumption, weight gain, and food efficency ratio
inrats fed varyingamountsofPb,Cd,and As.'
Treatment
Control
Pb
Cd
Inorg. Ay
Org. As
Pb x Cd
Pb x Inorg. As
Pb x Org. As
Cd x Inorg. As
Cd x Org. As
Pb x Cd x Inorg. As
Pb x Cd x Org. As
Food
consumption, g
1271 ± 28b
1232 ± 28
1217± 25
1098 26d
1119 ± 22d
1263 ± 21e
1107 ± 31
1068 ± 35
1060± 29
1083 ± 32
1115 ± 22
1126± 17
Bodywt.
gain,g
210 ± 7b
184 ± 6
173 ± 7C
164 ± 6d
154 ± 6d
175 ±6
180 ± 10
157 ± 9
140 ±9
147 ± 7'
138 ± 6'
156 ±6
Ratio Food
consumption/
weight gain
6.09 + 0.13b
6.77+0.19
7.14 ±+0.28
6.70 t 0.32
7.47 ± 0.38
7.23 ± 0.27
6.32 t 0.39
6.92 ± 0.28
7.83 t0.42f
7.61 ± 0.36
8.19 ± 0.34
7.27 ± 0.22
aSignificance levels may represent an increase or decrease
from control values.
bMean ± 1 SEM.
cp < 0.001
dp < 0.0001
ep <0.01
'p < 0.05
an increase in the number of circulating red blood
cells above that produced by either metal alone. Pb
or Cd alone did not result in significant reductions
in hemoglobin or hematocrit, however, inorganic
As alone reduced both hemoglobin and hematocrit.
The greatest decreases in hemoglobin and hemato-
crit were seen with the combination of Pb and Cd
and with Cd and organic As (Table 3). The number
ofperipheral white blood cells was decreased by Cd
but not significantly affected by Pb and As. Pb ef-
fects on heme synthesis can be seen by measuring
the urinary excretion ofdALA. Urinary dALA ex-
cretion was greatly increased by Pb, however, the
magnitude of this increase was decreased by the
presence of Cd (Table 4). Similar effects of Pb and
Cd on blood Pb concentration can be observed
(Table 4). Tissue Pb concentrations (kidney, liver,
and bone) are needed to confirm the probable re-
duction of body burden of Pb in the presence of
dietary Cd.
Analysis of blood showed values within the nor-
mal range for the laboratory rat for: blood urea ni-
trogen, creatinine, cholesterol, calcium, albumin,
total protein and bilirubin. Serum uric acid concen-
tration was increased by Pb (Table 5). Serum al-
kaline phosphatase activity was decreased by both
Cd and As, but was not affected by Pb (Table 5).
The combination of Cd and As resulted in even
greater reductions of alkaline phosphatase activity
than that resulting from either metal alone. Alkaline
phosphatase activity is derived from a number of
different isoenzymes. The specific isoenzyme(s) af-
fected by Cd or As were not determined in the cur-
rent study. SGOT activity was greatly reduced by
administration of As alone.
Both kidney weight and the kidney weight to
body weight ratio were increased by elevated levels
of Pb in the diet (Table 6). Cd and As were without
influence on these parameters (Table 6). The liver
weight/body weight ratio was decreased by dietary
Cd but not Pb or As. The effects of these metals
were also evaluated by light and electron micros-
copy.
Liver sections examined by light microscopy
from animals on the lead and cadmium treatment
specimens were indistinguishable from controls ex-
cept that some mild parenchymal cell swelling was
noted in animals exposed to either form of arsenic.
Renal changes characterized by cloudy swelling of
Table 3. Hematology values for rats fed varying amounts ofPb, Cd, and As.'
Treatment RBC x 106 Hemoglobin, g Hematocrit WBC x 103b
Control 6.81 + 0.5b 15.2 ± 0.3b 43.5 ± 0.7 6.39 ± 0.42
Pb 7.36 ± 0.26c 15.7 ± 0.6d 43.9 ± 0.7c 6.20 ± 0.39
Cd 8.27 ± 0.23e 15.1 ± 0.2d 41.8 ± 0.6d 4.95 ± 0.67c
Inorg. As 7.73 ± 0.11d 14.5 ± 0.3d 40.0 ± 0.7c 6.44 ± 0.54
Org. As 7.04 + 0.12d 15.7 ± 0.2d 43.5 ± 0.6c 6.13 ± 0.34
Pb x Cd 7.57 ± 0.25e 14.3 ± 0.3c 39.7 ± 0.8 5.74 ± 0.77
Pb x Inorg. As 7.97 ± 0.13e 15.3 ± 0.2d 42.8 ± 0.5e 7.39 ± 0.45
Pb x Org. As 8.46 ± 0.I9e 17.3 ± 0.2e 46.0 ± 1.2e 5.32 ± 0.40
Cd x Inorg. As 7.93 + 0.17e 15.3 ± 0.3e 42.0 ± 0.8e 5.58 ± 0.46
Cd x Org. As 8.01 ± 0.16e 14.5 ± 0.3e 39.6 ± 0.6e 6.04 ± 0.25
Pb x Cd x Inorg. As 7.51 ± 0.26 15.6 ± 0.3 42.5 ± 0.4 5.85 ± 0.72
Pb x Cd x Org. As 8.58 + 0.22 15.6 ± 0.2 43.6 ± 0.6 5.79 ± 0.65
aSignificance levels may represent an increase or decrease from control values.
bMean ± 1 SEM.
cp < 0.05
dp < 0.001
ep <0.0001
August 1977 167Table 4. Urinary 8aminolevulinic acid (dALA) excretion and
blood lead concentration of rats fed varying amounts
of Pb, Cd, and As.a
Urinary
dALA, Blood Pb,
Treatment mg/24 hr mgldl
Control 46.2 ± 7.lb 7.4 + 1.0b
Pb 115.5 + 12.7c 44.9 ± 1.7c
Cd 46.8 t 5.1d 6.2 t 1.2d
Inorg. As 41.8 t 7.3 5.3 ± 1.1
Org. As 35.8 t 7.5 3.2 ± 0.9
Pb x Cd 98.3 ± 9.4c 31.6 t 2.8e
Pb x Inorg. As 136.7 t 5.1 37.0 t 1.8f
Pb x Org. As 103.6 ± 9.9 42.1 ± 2.4'
Cd x Inorg. As 51.1 ± 8.2d 5.7 1.0d
Cd x Org. As 68.5 ± 11.3d 6.4 t 1.7d
Pb x Cd x Inorg. As 85.5 ± 11.0 34.3 ± 2.9
Pb x Cd x Org. As 96.7 ± 9.8 40.5 t 1.8
aSignificance levels may represent an increase or decrease
from control values.
bMean ± 1 SEM.
Cp <0.0001.
dp < 0.01.
ep < 0.001.
fp < 0.05.
Table S. Serum uric acid,alkaline phosphataseactivity, andserum
glutamate oxalate transaminase (SGOT) activity in rats fed
varying amounts of Pb, Cd, and As.a
Alkaline
Uricacid, phosphatase, SGOT,
Treatment mu/ml mu/ml mu/ml
Control 1.72 0.13b 201 12b 247 ± 24b
Pb 3.33 0.86c 195 11 240 ± 29d
Cd 2.02 0.08 134 6e 245 ± 21
Inorg. As 1.55 0.09 127 12e 159 ± 8c
Org.As 1.54±0.09 135 7e 174±9c
PbxCd 1.91±0.18 147±11 203±13
Pb x Inorg. As 1.63 0.14 136 ± 11 175 ± 13'
Pb x Org. As 2.42 0.17 143 ± 12 329 ± 46'
Cd x Inorg. As 1.92 0.17d 120 ± 10f 211 ±15d
Cd x Org. As 1.91 0.13d 117 ±5f 204
± 9d
Pb x Cd x Inorg.As 2.51 0.60 128 ± 12 238 ± 18
PbxCdxOrg.As 2.34±0.25 131±8 263±31
aSignificance levels may represent an increase or decrease
from control values
bMean ± 1SEM.
Cp < 0.01.
dp <0.05.
ep < 0.0001.
fp < 0.001.
Table 6. Renal and hepatic weights and ratios to body weight in rats fed varying amounts of Pb, Cd, and As.a
Ratio Ratio
Kidney Kidney wt. Liver Liverwt.
weight, Body wt. weight, Body wt.
Treatment g X 10-3 g X 10-3
Control 1.333 ± 0.040b 2.95 ± 0.06b 14.36 ± 0.46b 31.74 ± 0.79b
Pb 1.343 ± 0.057 3.21 ± 0.10c 13.61 ± 0.42 32.61 ± 0.71
Cd 1.186 ± 0.037 2.88 ± 0.08 12.32 z 0.20 30.01 ± 0.60'
Inorg. As 1.232 ± 0.033 3.10 ± 0.06 12.39 ± 0.30 31.31 ± 0.50
Org. As 1.196 ± 0.028 3.07 ± 0.08 11.89 ± 0.34 30.79 ± 0.72
Pb x Cd 1.320 ± 0.065 3.20 ± 0.17 12.47 ± 0.40 29.97 ± 0.85
Pb x Inorg. As 1.348 ± 0.051 3.25 ± 0.08 13.33 ± 0.58 32.13 ± 0.96
Pb x Org. As 1.275 ± 0.019 3.27 ± 0.10 12.44 ± 0.54 31.90 ± 0.91
Cd x Inorg. As 1.111 ± 0.042 3.12 ± 0.06 11.02 ± 0.45 30.48 ± 0.53
Cd x Org. As 1.202 ± 0.044 3.15 ± 0.14 11.48 ± 0.34 29.68 ± 0.45
Pb x Cd x Inorg. As 1.235 ± 0.027 3.24 ± 0.08 11.96 ± 0.32 30.85 ± 0.88
Pb x Cd x Org. As 1.214 ± 0.027 3.20 ± 0.09 11.51 ± 0.24 30.04 ± 0.60
aSignificance levels mayrepresent an increase ordecrease from control values.
bMean ± 1 SEM.
cp<0.001.
dp < 0.0001.
proximal tubule cells and intranuclear inclusion
bodies (Fig. 1) were observed in animals given diets
containing lead with the notable exception ofthose
animals concomitantly exposed to cadmium (Table
7). These animals had few intranuclear inclusions
and relatively little cloudy swelling. Morphological
changes in kidneys ofanimals exposed to combina-
tions ofcadmium or either arsenical were relatively
slight.
Discussion
The purpose of this study was to evaluate the
combined biological effects ofPb, Cd, and As inthe
rat. Significant interactions between allthree metals
were relatively infrequent. The most consistent in-
teractions were between Pb and Cd, between Cd
and As. Generally, the presence of other metals
reduced the magnitude of the Pb effect. Reduction
in efficiency ofconversion offood energy into body
weight gain was the most sensitive of the parame-
ters measured in this study for detecting interactions
of two or three metals. Reduced efficiency of food
conversion may be an indication of impaired ab-
sorption of nutrients from the gastrointestinal tract
or of a metabolic defect at the cellular level. Mea-
surements of cellular utilization ofcarbohydrates in
relation to oxidative phosphorylation and genera-
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FIGURE 1. Electron micrograph of a renal proximal tubule cell from a rat exposed to dietary lead. Note large fibrillar in-
tranuclear inclusion body. x 16,758.
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169Table 7. Relative incidenceoflead intranuclear inclusion bodies
inratsfeddietscontaining lead,cadmium, inorganic
ororganic arsenic.
Control 0/13
Pb 10/13
Cd 0/13
Inorg. As 0/13
Org As 0/13
Pb x Cd 0/13
Pb x Inorg. As 10/13
Pb x Org. As 11/13
Cd x Inorg. As 0/13
Cd x Org. As 0/13
Pb x Cd x Inorg. As 0/13
Pb x Cd x Org As 2/13
aNumberofrats with inclusions overnumberexamined.
tion ofhigh energy phosphate compounds would be
of interest. Pb (1), As (3), and Cd (2) are all known
to interfere with these processes.
From the morphological and biochemical data
currently available it appears that there may be
lower Pb absorption or retention at the higher level
of Cd intake. This can be confirmed only when
analyses oftissue Pb concentrations are completed.
However, if Cd reduces Pb absorption, it is of in-
terest to consider further a possible mechanism for
this change. Recent evidence indicates that vitamin
D increases gastrointestinal absorption of Pb when
added to the diet ofrats deficient in vitamin D (Dr.
Hector DeLuca, Department of Biochemistry,
University of Wisconsin, FDA contract report).
Feldman and Cousins (20) report that incubation of
Cd with kidney homogenates and isolated
mitochondria from vitamin D deficient chicks de-
creased formation of 1,25-dihydroxycholecalciferol
from 25-hydroxycholecalciferol. Chicks fed diets
containing 50 ppm Cd showed depressed produc-
tion of 1,25-dihydroxycholecalciferol in kidney
mitochondria.
Another mechanism which may reduce Pb ab-
sorption at high levels of dietary Cd is damage to
the absorptive surface of the gastrointestinal tract.
Richardson and Fox (21) report gross, microscopic,
and ultrastructural lesions in the proximal small in-
testine ofJapanese quail fed a diet containing 75 mg
Cd/kg. The villi were short and thick; the lamina
propria had adense cellular infiltrate; and microvilli
on absorptive villi were markedly shortened. Such
changes are similar to lesions occurring in some
malabsorption syndromes in humans.
The possible mechanisms through which Cd may
reduce body burden of Pb are of interest with re-
gard to establishment of safe levels of exposure to
toxic compounds in humans and animals. Reduc-
tion of body burden of a toxic substance, in this
example Pb, may be achieved through a mechanism
which is generally deleterious to the health of the
organism. Reduction of ability to absorb the toxic
compound Pb would be accompanied by reduced
ability to absorb nutritionally required elements as
well.
Many of the biochemical and hematological
parameters reported here have been investigated in
epidemiological or clinical studies ofhuman popula-
tions. These parameters, however, give only a clin-
ical endpoint picture of a complex metabolic situa-
tion and further studies are in process to elucidate
the biochemical mechanisms for these phenomena
in experimental animals. Rats fed higher levels of
dietary Pb showed significantly increased serum
uric acid concentrations. Concentrations of urate
above 3 mg/dl are unusual in the rat. Whether this is
a reflection of impaired renal excretion of urate by
the kidney or impaired metabolism of urate by uric
acid oxidase in the liver or kidney is not clear.
Gouty changes have been described in humans hav-
ing elevated body burdens of Pb (1). The specific
isoenzyme(s) involved in the observed reduction of
alkaline phosphatase activity by Cd and As in this
study are not known and will be examined in future
investigations. Varying degrees of inhibition ofdif-
ferent isoenzymes by a metal have been observed,
Kshirsagar (22) reported reduced kidney, liver and
intestinal alkaline phosphatase activity, but in-
creased bone alkaline phosphatase activity in rats
fed diets containing 2% stable strontium. Reduction
in SGOT activity was observed in animals fed high
levels of As. Administration of other metals, for
example, mercury (23)-have resulted in an increase
in SGOT, which generally reflects tissue damage.
Reduction of activity by dietary As may indicate
inhibition of the enzyme by As and further studies
are needed to examine this possibility.
The metabolic complexities of multi-element ex-
posure are also illustrated by hematological findings
in this study. All animals maintained fairly normal
hemoglobin concentrations even though excretion
of intermediates in porphyrin and heme synthesis
increased several fold. There is a substantial re-
serve capacity forformation ofhemoglobin which is
reflected in maintenance of effectively normal
hemoglobin concentrations despite two to three-
fold increases in excretion of intermediate prod-
ucts. Certainly not all heme synthesized goes to
the formation of hemoglobin. Maintenance of this
heme function, however, may have priority over
some other uses for heme such as heme-containing
enzymes. It may also be that the tissue or organ
systems synthesizing hemoglobin, such as bone
marrow, concentrate lowerlevels ofthe metals than
cells synthesizing heme for other compounds. Ab-
Environmental Health Perspectives 170sence of an effect in an end product such as hemo-
globin does not constitute an absence of metabolic
effect. Biochemical studies reported at this meeting
(24-26) examine these other effects of As more
thoroughly. This experiment probably has its
greatest usefulness in suggesting directions for
further research and the need for more specific
parameters to assess toxicity. Careful control of
nutritional conditions in studies of this type is
clearly essential to interpretation of toxicity data.
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